Financial report interval: 2025.12.31 - 2026.03.31
Preview: KELUN PHARMA(002422) predict that the Revenue is 4.259 B (-2.98%), Miss estimate;the EBIT is 356.49 M (-55.09%), Miss estimate;the EPS is 0.29 (-21.62%), Miss estimate.